Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells

Top Cited Papers
Open Access
Abstract
Multiple myeloma (MM) is an incurable plasma cell malignancy. The 26S proteasome inhibitor, bortezomib, selectively induces apoptosis in MM cells; ho